- Tytuł:
- Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial
- Autorzy:
- Źródło:
- In The Lancet 24-30 June 2023 401(10394):2124-2137
Czasopismo naukowe